ESR1 and breast cancer: Recent studies suggest that estrogen receptor α (ERα), the dominant regulator of estrogen action in breast tissue, regulates PARP7 expression and that PARP7 acts as a negative regulator of ERα activity via mono-ADP-ribosylation in BC cells (52, 53).